幹細胞治療市場

幹細胞治療市場 是由出版商Kalorama Information在2009年02月所出版的。 這份英文市場調查報告書包含150 pages 價格從美金2500起跳。

簡介

目錄

Abstract

Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S. Congress has also indicated a desire to move forward with stem cell research. The momentum in two branches of American government, along with scientific developments and the competition of world markets presages good market conditions for stem cell research.

With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells.

While companies have found opportunity outside the U.S., President Bush' s seven year limitations on embryonic stem cell research in the U.S. has limited the U.S. market. Changes in U.S. policy should open up U.S. markets. For market-watchers in the pharmaceutical industry, the question is what potential they have and where they could take the market. Kalorama Information has tackled that question in Stem Cells Therapeutics Markets. Kalorama analyst Alison Sahoo has built models to determine the best case and most likely case scenarios for therapeutic markets for stem cells in the coming years. This report breaks down forecasted revenues and procedure volumes for stem cell technologies for these segments in the following disease areas:

• Cardiovascular disease
• Lung disease
• Arthritis
• Incontinence
• Osteoporosis
• Diabetes
• Cancer
• Orthopedics
• Infertility
• Alzheimer' s disease
• Burns (severe)
• Lupus
• Parkinson' s disease
• Liver failure
• Multiple sclerosis
• Critical limb ischemia
• Crohn' s disease
• Sickle cell disease
• Multiple myeloma
• NH lymphoma
• Leukemia

Ths report is the result of exclusive interviews with executives in the stem cell industry, a review of medical and company literature, government databases and publications. As part of this comprehensive analysis of stem cell markets, the following companies were profiled:

• Aastrom Biosciences
• Advanced Cell Technologies
• Brainstorm Cell Therapeutics
• Celegene
• ES Cell International
• Medistem
• Neostem
• Opexa Therapeutics
• Osiris Therapeutics
• Plureon
• Regenetech
• Revivicor
• Stem Cell Sciences
• StemLifeLine
• ThermoGenesis
• VetCell Bioscience

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

• Recent Developments
• Introduction
• Current Stem Cell Therapies
• Developmental Stem Cell Therapies
• Issues in Stem Cell Research
• Stem Cell Forecasts
• Market Forecast
• The Promise of Stem Cells in Medical Treatment
• Types of Stem Cells
• Embryonic Stem Cells
• Important Developments in ES Cell Research
• Adult Stem Cells
• Important Developments
• Scope and Methodology

CHAPTER TWO: CURRENT STEM CELL THERAPIES

• Cancer
• Leukemia
• Gene Therapy
• Multiple Myeloma
• Non-Hodgkin' s Lymphoma Noncancerous Diseases
  • Aplastic Anemia
  • Immunodeficiency
  • Lupus
  • Sickle Cell Disease
  • Other Conditions

CHAPTER THREE: DEVELOPMENTAL STEM CELL THERAPIES

• Alzheimer' s Disease
• Arthritis
• Burns
• Cancer
• Cardiovascular Conditions
• Critical Limb Ischemia
• Crohn' s Disease
• Diabetes
• Incontinence
• Infertility
• Liver Failure
• Lung Disease
• Multiple Sclerosis
• Orthopedics
• Osteoporosis
• Parkinson' s Disease
• Sickle Cell Disease

CHAPTER FOUR: STEM CELL MARKET FORECASTS

• Best Case
  • Forecasts By Disease Area
  • Alzheimer' s Disease
  • Arthritis
  • Burns
  • Cancer,
  • Cardiovascular Conditions
  • Critical Limb Ischemia
  • Crohn' s Disease
  • Diabetes,
  • Incontinence
  • Infertility,
  • Liver Failure
  • Lung Disease
  • Multiple Sclerosis
  • Orthopedics
  • Osteoporosis
  • Parkinson' s Disease
  • Sickle Cell Disease
• Most Likely Case
  • Forecasts By Disease Area
  • Alzheimer' s Disease
  • Arthritis
  • Burns
  • Cancer,
  • Cardiovascular Conditions
  • Critical Limb Ischemia
  • Crohn' s Disease
  • Diabetes,
  • Incontinence
  • Infertility,
  • Liver Failure
  • Lung Disease
  • Multiple Sclerosis
  • Orthopedics
  • Osteoporosis
  • Parkinson' s Disease
  • Sickle Cell Disease

CHAPTER FIVE: COMPANY PROFILES

• Aastrom Biosciences
• Advanced Cell Technologies
• Athersys
• Brainstorm Cell Therapeutics
• Celegene
• ES Cell International
• Medistem
• MultiCell Technologies, Inc.
• Neostem
• Nephros Therapeutics, Inc.
• Opexa Therapeutics
• Osiris Therapeutics
• Plureon
• Regenetech
• Revivicor
• Stem Cell Sciences
• ThermoGenesis
• VetCell Bioscience

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

• Table 1-2: Stem Cell Therapeutics Market in $ Millions, 2007-2020

CHAPTER TWO: CURRENT STEM CELL THERAPIES

• Table 2-1: Types of Leukemia, 2007

CHAPTER THREE: DEVELOPMENTAL STEM CELL THERAPIES

• Table 3-1: Global Disease Populations Addressed by Potential Stem Cell Therapies, 2007
• Table 3-2: Estimated and Projected World Cancer Incidence by Selected Types of Cancer, 2007 and 2020
• Table 3-3: Estimated and Projected World Cancer Mortality by Selected Types of Cancer, 2007 and 2020
• Table 3-4: Types and Features of Urinary Incontinence, 2007
• Table 3-5: Types and Causes of Male Infertility, 2007
• Table 3-6: Common Diseases of the Lungs, 2007

CHAPTER FOUR: STEM CELL MARKET FORECASTS

• Table 4-1: Persons Affected by Key Stem Cell Therapeutic Targets in Millions, 2007
• Table 4-2: Best Case: Procedure Volume for Proprietary Stem Cell Therapies by Disease in Millions, 2007 - 2020(Alzheimer' s Disease, Arthritis, Burns, Cancer, Cardiovascular Conditions, Critical Limb Ischemia, Crohn' s Disease, Diabetes, Incontinence, Infertility, Liver Failure, Lung Disease, Multiple Sclerosis, Orthopedics, Osteoporosis, Parkinson' s Disease, Sickle Cell Disease)
• Table 4-3: Best Case: Revenues for Proprietary Stem Cell Therapies by Disease in $ Millions, 2007 - 2020(Alzheimer' s Disease, Arthritis, Burns, Cancer, Cardiovascular Conditions, Critical Limb Ischemia, Crohn' s Disease, Diabetes, Incontinence, Infertility, Liver Failure, Lung Disease, Multiple Sclerosis, Orthopedics, Osteoporosis, Parkinson' s Disease, Sickle Cell Disease)
• Table 4-4: Most Likely Case: Procedure Volume for Proprietary Stem Cell Therapies by Disease in Millions, 2007 - 2020(Alzheimer' s Disease, Arthritis, Burns, Cancer, Cardiovascular Conditions, Critical Limb Ischemia, Crohn' s Disease, Diabetes, Incontinence, Infertility, Liver Failure, Lung Disease, Multiple Sclerosis, Orthopedics, Osteoporosis, Parkinson' s Disease, Sickle Cell Disease)
• Table 4-5: Most Likely Case: Revenues for Proprietary Stem Cell Therapies by Disease in $ Millions, 2007-2020(Alzheimer' s Disease, Arthritis, Burns, Cancer, Cardiovascular Conditions, Critical Limb Ischemia, Crohn' s Disease, Diabetes, Incontinence, Infertility, Liver Failure, Lung Disease, Multiple Sclerosis, Orthopedics, Osteoporosis, Parkinson' s Disease, Sickle Cell Disease)

CHAPTER FIVE: COMPANY PROFILES

• Table 5-1: Therapeutic Focus of Selected Stem Cell Therapeutics Companies, 2007

相關商品

細胞療法相關市場調查報告書

神經幹細胞·前驅細胞產品的策略性開發

Strategic Development of Neural Stem & Progenitor Cell Products

價格 : US $ 3495

出版日期 : 2012年01月

細胞治療:技術˙市場˙企業

Cell Therapy - Technologies, Markets and Companies

價格 : US $ 5500

出版日期 : 2012年01月

個別化醫療：科學的・商業的情勢

Personalized Medicine - scientific & commercial aspects

價格 : US $ 5000

出版日期 : 2012年01月

Kalorama Information發行的生物科技相關市場調查報告書

幹細胞：全球的幹細胞移植・臍帶血銀行・藥劑開發市場

Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development

價格 : US $ 3995

出版日期 : 2012年01月

細胞培養:全球培養基·血清·試劑市場(第3版)

Cell Culture: The World Market for Media, Sera and Reagents, 3rd. Edition

價格 : US $ 3500

出版日期 : 2011年10月

全球癌症治療和生物療法市場:第4版

The World Market for Cancer Therapeutics and Biotherapeutics, 4th Edition

價格 : US $ 3500

出版日期 : 2011年10月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!